Studies on anti-leukemic substance, cordacin. I. Isolation and characterization.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D001835:Body Weight; D002051:Burkitt Lymphoma; D002460:Cell Line; D002478:Cells, Cultured; D003460:Crystallization; D006801:Humans; D066298:In Vitro Techniques; D007938:Leukemia / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D051379:Mice; D008938:Mitosis / Q000187:drug effects; D010936:Plant Extracts / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D010946:Plants, Medicinal; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet; D013624:Taiwan
D000970:Antineoplastic Agents; D010936:Plant Extracts